converting between glp-1 agonists Mapping the effectiveness and risks of receptor GLP-1 receptor agonist use may

In the UK, NICE recommends GLP-1 receptor agonists for type 2 diabetes in specific circumstances (NG28), such as when metformin is insufficient and BMI 30 kg/m

Allulose and GLP-1 Secretion: What In Vitro and Animal Studies Reveal In vitro and rodent studies suggest allulose may trigger GLP-1 secretion from intestinal L-cells more robustly than glucose, possibly by modulating sweet taste receptors (TAS1R2/TAS1R3) or metabolic sensors

*For eligible Medicare Part D patients with qualifying GLP-1 medication prescription for weight management

For some people, this can help restart weight loss

SOURCE: American College of Chest Physicians, news release, Oct

Twelve- and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes